Prevalence and Incidence of Monomelic Amyotrophy
Monomelic Amyotrophy: Rare Disease
Monomelic Amyotrophy is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Monomelic Amyotrophy, or a subtype of Monomelic Amyotrophy,
affects less than 200,000 people in the US population.
Ophanet, who are a consortium of European partners,
currently defines a condition rare when if affects 1 person per 2,000.
They list Monomelic Amyotrophy as a "rare disease".
More information about Monomelic Amyotrophy is available from Orphanet
About prevalence and incidence statistics:
The term 'prevalence' of Monomelic Amyotrophy usually refers to the estimated population
of people who are managing Monomelic Amyotrophy at any given time.
The term 'incidence' of Monomelic Amyotrophy refers to the annual diagnosis rate,
or the number of new cases of Monomelic Amyotrophy diagnosed each year.
Hence, these two statistics types can differ:
a short-lived disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.